[Triglycerides, HDL and coronary disease. Consensus conference: National Institutes of Health 1992]
Related Experiment Videos
1Lipidklinikken, Medisinsk avdeling A, Rikshospitalet, Oslo.
Insights
The panel recommends measuring HDL-cholesterol due to its causal link to heart disease. A full lipid profile, including serum triglycerides, is advised for hyperlipidemia treatment.
Area of Science:
- Cardiology
- Lipidology
- Public Health
Background:
- The panel reviewed evidence linking High-Density Lipoprotein (HDL)-cholesterol to coronary heart disease (CHD).
- Associations between serum triglycerides and CHD are noted, but causal evidence remains incomplete.
- Current Norwegian guidelines for hypercholesterolemia treatment were considered.
Framework:
- The review focused on the causal relationship between HDL-cholesterol and CHD.
- Analysis included the ambiguity of data regarding serum triglycerides and their association with cardiovascular events.
- The existing Norwegian program for hypercholesterolemia management served as a reference point.
Implementation:
- Increased emphasis on measuring HDL-cholesterol is recommended.
- A comprehensive initial lipid profile should incorporate serum triglyceride determination.
- These measurements are crucial for effective hyperlipidemia evaluation and treatment.
Implications:
- The findings support the continued appropriateness of current Norwegian recommendations for hyperlipidemia.
- Enhanced lipid profiling can lead to more accurate diagnosis and tailored treatment strategies.
- This approach contributes to improved cardiovascular disease prevention and management.
Abstract:
The article describes the conclusions and recommendations of the panel. A review of the information on HDL-cholesterol and coronary heart disease provides considerable evidence of a causal relationship. In the case of serum triglycerides, the data are ambiguous; although strong associations are found in some studies, evidence of a causal relation is still incomplete. Seen in relation to the latest Norwegian programme for treatment of hypercholesterolemia in adults, greater emphasis should be placed on measuring HDL-cholesterol. A complete initial lipid profile should also include determination of serum triglycerides. When taking these factors into consideration, the present Norwegian recommendations seem to be appropriate for evaluating and treating hyperlipidemia.